Impact of Intraoperative Neurophysiological Monitoring on Surgery of High-Grade Gliomas

被引:63
|
作者
Kombos, Theodoros [1 ]
Picht, Thomas [1 ]
Derdilopoulos, Athanasios [1 ]
Suess, Olaf [1 ]
机构
[1] Charite, Dept Neurosurg, D-12200 Berlin, Germany
关键词
Intraoperative monitoring; Glioma; SUPRATENTORIAL MALIGNANT GLIOMAS; RECURSIVE PARTITIONING ANALYSIS; MOTOR EVOKED-POTENTIALS; QUALITY-OF-LIFE; GLIOBLASTOMA-MULTIFORME; BRAIN-TUMORS; LANGUAGE LOCALIZATION; CORTICAL LOCALIZATION; SURGICAL-MANAGEMENT; FUNCTIONAL OUTCOMES;
D O I
10.1097/WNP.0b013e3181c2c0dc
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Controversy exists on the application of intraoperative monitoring (IOM) procedures during malignant glioma surgery. Because resection rate correlates with the survival rate, it is of paramount importance to determine these values. This study evaluates the impact of IOM on the resection rates, the survival rate, the quality of life, and the functional outcome of malignant gliomas. Methods: Forty patients with a glioma were included in the study. They were divided into two groups: group 1, patients with a glioma not adjacent to motor cortical areas operated without the use of IOM, and group 2, patients with a glioma adjacent to the central region operated under IOM. The further treatment was the same in both groups. The following parameters were analyzed: tumor resection rate, survival rate, preoperative and postoperative Karnowsky Performance Score, and preoperative and postoperative motor function. Results: There were no statistically significant differences in the type of surgery performed or in the resection grade in both groups. No statistically significant difference was found in the median survival of the two groups in the Kaplan-Meier analysis with mean survival time 48.8 and 48.2 weeks. The mean Karnowsky Performance Score preoperative was 82.5 and 81.5, and 81.1 and 82.7 after 6 months, for groups 1 and 2, respectively. Conclusion: The data presented here demonstrate that tumor resection is not negatively influenced by IOM. Accordingly, gliomas that are found to be otherwise resectable should not be excluded from aggressive management simply because of their vicinity to the motor cortex. Surgery should be performed under IOM.
引用
收藏
页码:422 / 425
页数:4
相关论文
共 50 条
  • [41] VENOUS THROMBOEMBOLISM AND HIGH-GRADE GLIOMAS
    DHAMI, MS
    BONA, RD
    CALOGERO, JA
    HELLMAN, RM
    THROMBOSIS AND HAEMOSTASIS, 1993, 70 (03) : 393 - 396
  • [42] BEVACIZUMAB FOR RECURRENT HIGH-GRADE GLIOMAS
    Sahebjam, Solmaz
    Garoufalis, Evgenia
    Guiot, Marie Christine
    Muanza, Thierry
    Del Maestro, Ronaldo
    Kavan, Petr
    NEURO-ONCOLOGY, 2010, 12 : 43 - 43
  • [43] Thalidomide in the treatment of high-grade gliomas
    Cohen, MH
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (19) : 3453 - 3453
  • [44] INTRAOPERATIVE ASPIRATE TISSUE MONITORING DURING 5-ALA GUIDED HIGH-GRADE GLIOMA SURGERY
    Elomaa, A.
    Lehtonen, S.
    Fraunberg, M. von Und Zu
    Charbel, F.
    Luoma, J.
    Visuri, M.
    Haapala, I
    Haapasalo, J.
    Vik-Mo, E.
    Puustinen, S.
    NEURO-ONCOLOGY, 2024, 26
  • [45] Antiangiogenic Therapy for High-Grade Gliomas
    Chamberlain, Marc C.
    Raizer, Jeff
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (03) : 184 - 194
  • [46] Management of High-Grade Gliomas in the Elderly
    Ferguson, Michelle
    Rodrigues, George
    Cao, Jeffrey
    Bauman, Glenn
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (04) : 279 - 288
  • [47] Treatment advances in high-grade gliomas
    Chen, Xi
    Cui, Yi
    Zou, Liqun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [48] Advanced treatment in high-grade gliomas
    Xiong, Lai
    Wang, Feng
    Xie, Xiao Qi
    JOURNAL OF BUON, 2019, 24 (02): : 424 - 430
  • [49] Temozolomide for Pediatric High-Grade Gliomas
    Roger J. Packer
    Current Neurology and Neuroscience Reports, 2012, 12 (2) : 111 - 113
  • [50] High-grade gliomas: reality and hopes
    Mirimanoff, Rene-Olivier
    CHINESE JOURNAL OF CANCER, 2014, 33 (01) : 1 - 3